Hemodialysate: An Evidence-Based Guide for Patients

Hemodialysate usually refers to a highly filtered extract derived from calf blood that is marketed in some regions for wound healing, circulation-related symptoms, or nerve conditions. Its proposed effects remain under study, and strong evidence supporting routine use for most conditions is limited.

What is hemodialysate?

Hemodialysate generally means a filtered biological extract made from calf blood. In medical literature and product information, it may also be called deproteinized calf blood hemodialysate, calf blood ultrafiltrate, or a deproteinized hemoderivative. The manufacturing process aims to remove large proteins and cells, leaving a mixture of small molecules that may include amino acids, electrolytes, sugars, and other low-molecular-weight substances.

It is important not to confuse hemodialysate with dialysate. Dialysate is the carefully prepared fluid used during kidney dialysis to help remove waste products from the blood. Hemodialysate is instead a medicine-related biological extract that has been marketed in certain countries, often under different brand names and in topical, oral, or injectable forms.

Manufacturers have proposed that hemodialysate may support cellular energy use or tissue repair under conditions of reduced oxygen supply. These proposed mechanisms do not by themselves establish that a product improves meaningful health outcomes. The benefit of any treatment must be assessed through well-designed human clinical studies, together with its safety, quality controls, and suitability for the individual patient.

Why might hemodialysate be used?

Depending on the country and the specific product, hemodialysate has been used or promoted for a range of concerns. These can include slow-healing skin wounds, burns, diabetic foot ulcers, symptoms associated with impaired circulation, nerve injury, and recovery after certain tissue injuries. Topical preparations may be used on the skin, while injectable forms are intended for administration by trained healthcare professionals only.

Some people encounter the term while searching for treatments for chronic wounds or diabetes-related complications. A chronic wound needs a careful medical assessment because poor healing can result from infection, reduced blood flow, pressure, nerve damage, high blood glucose, poor nutrition, or several factors at once. Addressing the underlying cause is usually more important than relying on any single topical or supportive product.

For example, diabetic foot care may require regular foot checks, pressure relief, wound debridement when appropriate, infection treatment, blood glucose management, and assessment of circulation. A clinician can determine whether a wound needs urgent attention and whether referral to a wound-care, vascular, diabetes, or surgical team is appropriate.

What does the evidence show?

The evidence for hemodialysate is not equally strong across all proposed uses. Some small clinical studies and laboratory research have reported possible benefits in wound healing or selected nerve-related symptoms. However, many available studies are small, use different products and treatment methods, have limited follow-up, or do not provide the level of rigorous comparison needed to confirm a reliable benefit.

High-quality evidence should show that a treatment improves outcomes that matter to patients, such as complete wound healing, pain, function, prevention of complications, or quality of life. It should also demonstrate safety in sufficiently large and varied groups of people. At present, major international clinical guidelines do not generally place hemodialysate among standard first-line treatments for most conditions for which it is marketed.

This does not mean that every individual product is ineffective. Rather, it means that the available research may not be enough to support routine use with confidence. Patients should ask a clinician what evidence applies to their specific diagnosis, whether established alternatives are available, and how any proposed treatment will be monitored.

Evidence-based care for wounds, nerve symptoms, and circulation problems often includes a combination of treating the cause, managing symptoms, preventing complications, and reviewing progress over time. A treatment that delays assessment of infection, poor circulation, or an underlying disease can be harmful even if it appears to offer temporary improvement.

Safety, quality, and regulatory considerations

Because hemodialysate is derived from animal material, product quality and manufacturing oversight are especially important. Processing methods are designed to reduce proteins and other larger components, but patients should use only products that are legally supplied and prescribed or recommended by a qualified clinician in their country. Products purchased online or obtained outside regulated channels may have uncertain ingredients, storage conditions, or authenticity.

Possible adverse effects depend on the product form and route of administration. Allergic or hypersensitivity reactions are a concern with biological products. Injectable treatments may also carry risks related to administration, including local reactions. A person should seek urgent medical help for signs of a severe allergic reaction, such as trouble breathing, swelling of the face or throat, widespread hives, faintness, or rapidly worsening symptoms.

Regulatory status varies. Some hemodialysate-containing products are available in selected countries, whereas others are not authorized in places such as the United States. Lack of approval in a particular country does not automatically prove that a product is unsafe, but it does indicate that patients should not assume it has been reviewed or recommended by local health authorities.

Pregnant or breastfeeding people, children, older adults, and people with multiple medical conditions should be particularly cautious. There may be limited safety data for these groups. A doctor or pharmacist can review possible risks, allergies, other medicines, and whether a treatment is appropriate.

How clinicians assess wounds and related symptoms

When hemodialysate is being considered for a wound or tissue-healing concern, the first step should be a clear diagnosis. A healthcare professional will usually ask how and when the problem began, whether it is changing, and whether there is pain, numbness, fever, discharge, or difficulty using the affected area. They may examine the skin, nerves, pulses, circulation, and sensation.

For a persistent wound, assessment may include checking for diabetes, poor blood supply, infection, pressure injury, vein problems, or inflammatory skin conditions. Blood tests, wound sampling, ultrasound, or other imaging may be needed in selected cases. These tests are not performed for every wound, but they can help identify a cause that needs targeted treatment.

People with tingling, burning, weakness, or numbness also need evaluation rather than self-treatment. Such symptoms can arise from diabetes, vitamin deficiencies, medication effects, nerve compression, thyroid disease, alcohol use, or other neurological conditions. Identifying the cause can lead to treatments with clearer evidence and may help prevent progression.

Practical guidance for patients

Patients considering hemodialysate can take a measured approach. They should ask the prescribing clinician what condition is being treated, what the intended benefit is, how long treatment is expected to continue, and how success will be measured. It is also reasonable to ask about the quality of the evidence, possible adverse effects, and alternatives that are supported by clinical guidelines.

A person should never inject a medication or use an intravenous product without professional supervision. It is also not advisable to substitute hemodialysate for recommended care such as antibiotic treatment for a confirmed infection, pressure off-loading for a foot ulcer, blood sugar management, or vascular assessment for reduced circulation.

For skin wounds, general self-care may include keeping the area clean as advised, avoiding unapproved home remedies, protecting the wound from pressure or friction, and following dressing instructions. People with diabetes should inspect their feet regularly, wear well-fitting footwear, and seek prompt advice for blisters, cuts, color changes, swelling, or areas of reduced sensation.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support international patients who need assessment and treatment for wounds, circulation concerns, diabetes complications, and related health needs.

When to seek medical care

Medical care is advisable for any wound that is deep, enlarging, painful, not improving, or present for more than a short period, especially in a person with diabetes, reduced circulation, immune suppression, or reduced sensation. A clinician should assess wounds caused by burns, bites, trauma, or surgery if there are concerns about healing.

Prompt medical evaluation is needed for spreading redness, warmth, swelling, pus or foul-smelling drainage, fever, red streaks, increasing pain, black or blue skin discoloration, or a wound that exposes deeper tissue. These signs can indicate infection or a blood-flow problem and should not be managed with a topical product alone.

Urgent care is also appropriate for sudden weakness, severe numbness, a cold or pale limb, chest pain, shortness of breath, confusion, or symptoms of a serious allergic reaction after any medication. Early assessment helps clinicians identify the cause and provide the safest treatment plan.

Frequently asked questions

Is hemodialysate the same as dialysis?

No. Dialysis is a treatment that filters waste and excess fluid from the blood when the kidneys cannot do so adequately. Hemodialysate usually refers to a filtered calf-blood extract used in some medical products, while dialysate is the fluid used during dialysis treatment.

Is hemodialysate proven to heal wounds?

Some studies suggest possible benefits for certain wounds, but the overall evidence is limited and inconsistent. Standard wound care, treating infection when present, reducing pressure, and assessing circulation remain central to safe wound management.

Can hemodialysate be used for diabetic foot ulcers?

A diabetic foot ulcer requires medical assessment because infection, nerve damage, pressure, and poor circulation may all affect healing. Hemodialysate should not replace established diabetic foot care or specialist review.

Is hemodialysate approved in every country?

No. Availability and regulatory authorization differ between countries and products. Patients should check with a local doctor or pharmacist rather than relying on online advertising or products obtained from unregulated sources.

What side effects can hemodialysate cause?

The potential side effects vary by formulation and route of use, but allergic reactions and local reactions can occur. Anyone who develops breathing difficulty, facial swelling, widespread rash, faintness, or rapidly worsening symptoms should seek urgent care.

Should someone use injectable hemodialysate at home?

Injectable products should only be used under the direction of an appropriately qualified healthcare professional. Self-injection or intravenous use without supervision can create avoidable risks and may delay diagnosis of the underlying problem.

References

• World Health Organization
• U.S. Food and Drug Administration
• National Institute for Health and Care Excellence
• International Working Group on the Diabetic Foot
• Cochrane Library

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.